Given that IDO1 was one of the most highly upregulated genes in our profiling of ccRCC tumors from, subjects with obesity, we also evaluated the enzymatic activity of plasma IDO to determine if IDO changes were specific to the tumor microenvironment or if these could be detected peripherally. This evidence concerns the gene IDO1 and nonpapillary renal cell carcinoma.